RHÖN-KLINIKUM Aktiengesellschaft EBIT

The latest EBIT for RHKJF is $56M as of June 2026. That compares with $54M in the prior-year period — up 2.8% year over year. That is above the sector sector average of $-25M. Investors often review this figure alongside RHÖN-KLINIKUM Aktiengesellschaft's historical trend and sector peers before judging valuation or financial health.

Over the past year, RHKJF's EBIT moved from $54M to $56M — a 2.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RHÖN-KLINIKUM Aktiengesellschaft's operating scale or balance-sheet position.

Against its sector companies, RHKJF currently prints $56M for EBIT, while the sector average sits near $-25M. That is roughly 320.3% above the sector mean. Large gaps often invite a closer look at RHÖN-KLINIKUM Aktiengesellschaft's growth, margins, and balance sheet.

A EBIT figure of $56M for RHKJF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-25M. Explore the charts below for those layers of context.

After noting RHKJF's EBIT ($56M), review year-over-year change from $54M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.